The Office of National Drug Control Policy has launched a new online training program to help doctors prescribe opioids more safely and effectively. The program’s goal is to reduce prescription drug abuse, The Boston Globe reports.
Category results for "Government"
The federal government will decide within the next month whether nurse anesthetists can be reimbursed by Medicare for treating chronic pain, The Wall Street Journal reports. Some doctors say such a move could complicate the fight against prescription drug abuse.
The Food and Drug Administration is launching a new campaign to warn consumers to avoid buying medicine from fraudulent online pharmacies. The National Association of Boards of Pharmacy estimates that less than 3 percent of online pharmacies meet state and federal laws.
A growing number of Amtrak employees have been testing positive for drugs and alcohol, increasing the risk of a serious railroad accident, according to a new report.
Estimates vary widely about how much tax might be collected from marijuana sales if recreational use of the drug is approved by voters in Colorado, Oregon and Washington this November, the Associated Press reports.
Almost six million Americans will face a tax penalty under the Affordable Care Act for not obtaining health insurance, according to an estimate from the Congressional Budget Office.
The federal government has launched two pilot programs designed to make prescription drug monitoring programs easier for doctors to use, American Medical News reports.
The Drug Enforcement Administration has revoked the licenses to dispense controlled substances for two CVS pharmacies in Florida, after accusing them of dispensing excessive amounts of oxycodone.
Nine former administrators of the U.S. Drug Enforcement Administration have written a letter to Attorney General Eric Holder, urging him to oppose three state measures on the ballot this November that would legalize recreational marijuana.
With Election Day just around the corner, voters in multiple locations will again be confronted with cannabis-related questions. Stuart Gitlow, MD, MPH, Acting President of the American Society of Addiction Medicine, says “medical marijuana” has simply been the camel’s nose under the tent, with the true goal of legalization covered up with a supposedly scientific approach.